Literature DB >> 25590505

Chronicity factors of temporomandibular disorders: a critical review of the literature.

Gui Maísa Soares1, Célia Marisa Rizzatti-Barbosa2.   

Abstract

Facial pain often persists long after any identifiable organic pathology has healed. Moreover, in a subgroup of patients with temporomandibular disorder (TMD), no treatment is effective. Knowledge of factors associated with persistent pain in TMD could help identify personalized treatment approaches. Therefore, we conducted a critical review of the literature for the period from January 2000 to December 2013 to identify factors related to TMD development and persistence. The literature findings showed that chronic TMD is marked by psychological distress (somatization and depression, affective distress, fear of pain, fear of movement, and catastrophizing) and characteristics of pain amplification (hyperalgesia and allodynia). Furthermore, these factors seem to interact in TMD development. In addition, our review demonstrates that upregulation of the serotonergic pathway, sleep problems, and gene polymorphisms influence the chronicity of TMD. We conclude that psychological distress and pain amplification contribute to chronic TMD development, and that interactions among these factors complicate pain management. These findings emphasize the importance of multidisciplinary assistance in TMD treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25590505     DOI: 10.1590/1807-3107BOR-2015.vol29.0018

Source DB:  PubMed          Journal:  Braz Oral Res        ISSN: 1806-8324


  9 in total

1.  Influence of Depression and Anxiety in Temporomandibular Disorders Six Months Postarthrocentesis.

Authors:  Marina Alexandra Gavín Clavero; María Victoria Simón Sanz; Úrsula María Jariod Ferrer; Andrea Mur Til; Julia Blasco Palacio; Eduard Mirada Donisa
Journal:  J Maxillofac Oral Surg       Date:  2021-01-07

2.  White Matter Diffusion Properties in Chronic Temporomandibular Disorders: An Exploratory Analysis.

Authors:  Alexandra S Budd; Thi K T Huynh; Peter Seres; Christian Beaulieu; Susan Armijo-Olivo; Jacqueline Cummine
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-21

3.  The use of conventional transcutaneous electrical nerve stimulation in chronic facial myalgia patients.

Authors:  Ilaria De Giorgi; Tommaso Castroflorio; Barbara Sartoris; Andrea Deregibus
Journal:  Clin Oral Investig       Date:  2016-03-22       Impact factor: 3.573

4.  Somatosensory profiles of patients with chronic myogenic temporomandibular disorders in relation to their painDETECT score.

Authors:  C Welte-Jzyk; D B Pfau; A Hartmann; M Daubländer
Journal:  BMC Oral Health       Date:  2018-08-09       Impact factor: 2.757

5.  Temporomandibular disorders: improving outcomes using a multidisciplinary approach.

Authors:  Miriam Garrigós-Pedrón; Ignacio Elizagaray-García; Adelaida A Domínguez-Gordillo; José Luis Del-Castillo-Pardo-de-Vera; Alfonso Gil-Martínez
Journal:  J Multidiscip Healthc       Date:  2019-09-03

6.  Alexithymia and facial emotion recognition in patients with craniofacial pain and association of alexithymia with anxiety and depression: a systematic review with meta-analysis.

Authors:  Roy La Touche; Alberto García-Salgado; Ferran Cuenca-Martínez; Santiago Angulo-Díaz-Parreño; Alba Paris-Alemany; Luis Suso-Martí; Aida Herranz-Gómez
Journal:  PeerJ       Date:  2021-11-29       Impact factor: 2.984

7.  Poorer sleep quality in patients with chronic temporomandibular disorders compared to healthy controls.

Authors:  Yeon-Hee Lee; Q-Schick Auh; Jung-Sub An; Tae Kim
Journal:  BMC Musculoskelet Disord       Date:  2022-03-14       Impact factor: 2.362

Review 8.  Temporomandibular pain.

Authors:  S Raghavendra Prasad; N Ravi Kumar; H R Shruthi; S D Kalavathi
Journal:  J Oral Maxillofac Pathol       Date:  2016 May-Aug

Review 9.  Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions.

Authors:  Alfonso Gil-Martínez; Alba Paris-Alemany; Ibai López-de-Uralde-Villanueva; Roy La Touche
Journal:  J Pain Res       Date:  2018-03-16       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.